Bangkok Dusit Medical Services Public Co. Ltd. (BDMS) Stock Statistics & Valuation Metrics
Total Valuation
Bangkok Dusit Medical Services Public Co. Ltd. has a market cap or net worth of THB 316.25B. The enterprise value is THB 325.90B.
- Market Cap
- THB 316.25B
- Enterprise Value
- THB 325.90B
Share Statistics
Bangkok Dusit Medical Services Public Co. Ltd. has 15,892,002,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,892,002,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bangkok Dusit Medical Services Public Co. Ltd.’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.67%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.10
- Return on Invested Capital (ROIC)
- 10.67%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 9.59M
- Profits Per Employee
- 1.36M
- Employee Count
- 11,628
- Asset Turnover
- 0.71
- Inventory Turnover
- 21.21
Valuation Ratios
The current PE Ratio of Bangkok Dusit Medical Services Public Co. Ltd. is 20.73. Bangkok Dusit Medical Services Public Co. Ltd.’s PEG ratio is -3.05.
- PE Ratio
- 20.73
- PS Ratio
- 2.83
- PB Ratio
- 3.06
- Price to FCF
- 24.67
- Price to Operating Cash Flow
- 14.61
- PEG Ratio
- -3.05
Income Statement
In the last 12 months, Bangkok Dusit Medical Services Public Co. Ltd. had revenue of 111.51B and earned 15.85B in profits. Earnings per share was 1.00.
- Revenue
- 111.51B
- Gross Profit
- 38.92B
- Operating Income
- 18.46B
- Pretax Income
- 20.06B
- Net Income
- 15.85B
- EBITDA
- 25.31B
- Earnings Per Share (EPS)
- 1.00
Cash Flow
In the last 12 months, operating cash flow was 21.65B and capital expenditures -8.84B, giving a free cash flow of 12.82B billion.
- Operating Cash Flow
- 21.65B
- Free Cash Flow
- 12.82B
- Free Cash Flow per Share
- 0.81
Dividends & Yields
Bangkok Dusit Medical Services Public Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.03%
- Dividend Per Share
- ―
- Dividend Yield
- 5.03%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.05%
- Earnings Yield
- 4.84%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- 6.99%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 57.63
- Average Volume (3m)
- 73.09M
Important Dates
Bangkok Dusit Medical Services Public Co. Ltd. upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
Bangkok Dusit Medical Services Public Co. Ltd. as a current ratio of 0.98, with Debt / Equity ratio of 16.51%
- Current Ratio
- 0.98
- Quick Ratio
- 0.83
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 0.44
- Interest Coverage Ratio
- 51.78
Taxes
In the past 12 months, Bangkok Dusit Medical Services Public Co. Ltd. has paid 3.69B in taxes.
- Income Tax
- 3.69B
- Effective Tax Rate
- 0.18
Enterprise Valuation
Bangkok Dusit Medical Services Public Co. Ltd. EV to EBITDA ratio is 13.13, with an EV/FCF ratio of 25.86.
- EV to Sales
- 2.96
- EV to EBITDA
- 13.13
- EV to Free Cash Flow
- 25.86
- EV to Operating Cash Flow
- 15.31
Balance Sheet
Bangkok Dusit Medical Services Public Co. Ltd. has THB 3.92B in cash and marketable securities with THB 19.08B in debt, giving a net cash position of -THB 15.16B billion.
- Cash & Marketable Securities
- THB 3.92B
- Total Debt
- THB 19.08B
- Net Cash
- -THB 15.16B
- Net Cash Per Share
- -THB 0.95
- Tangible Book Value Per Share
- THB 5.46
Margins
Gross margin is 35.40%, with operating margin of 15.74%, and net profit margin of 13.70%.
- Gross Margin
- 35.40%
- Operating Margin
- 15.74%
- Pretax Margin
- 17.37%
- Net Profit Margin
- 13.70%
- EBITDA Margin
- 22.59%
- EBIT Margin
- 16.13%
Analyst Forecast
The average price target for Bangkok Dusit Medical Services Public Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 1.30%
- EPS Growth Forecast
- -6.68%
